Comai Diagnosis: Shareholders holding more than 5% of the shares plan to reduce their holdings by no more than 0.67%.

Korler Diagnostics announcement states that as of the disclosure date of the announcement, shareholder Jinkangrui holds 22,710,535 shares of the company, accounting for 5.66% of the total share capital. Due to the upcoming expiration of the fund, it plans to reduce its holdings through centralized auction trading from June 25th to September 24th by no more than 2,700,000 shares, accounting for no more than 0.67% of the total share capital of the company, with the sale price determined by the market price. This reduction will not have a significant impact on the company's governance and operations. The quantity and price of the reduction are uncertain, so investors are reminded to be cautious of risks.